Complications of chronic liver disease. Edited by William G. Rector, Jr., 383 pp. St. Louis: Mosby–Year Book, 1992. $65doi:10.1002/hep.1840160533HenryMt.C.Mt.BodenheimerMt.WileyHepatology
VOD is thought to be caused by damage to the hepatic endothelium and leads to obliteration of hepatic sinusoids and hepatocyte necrosis. Incidence of VOD is thought to be approximately 14%, though estimates vary. Diagnosis is based on clinical findings (table) including hep- atomegaly, elevated ...
The hemodialysis procedure places patients at risk of acquiring infections. Studies have repeatedly demonstrated that infections can be prevented in the hemodialysis setting. We will discuss prevention of infections and infectious complications with a particular emphasis on the role of infection prevention f...
of heprain,147 patients subjected to interventional therapy were divided into three groups.In Group A of 47 patients,artery sheath catheter was removed immediately after interventional therapy,while in Group B of 49 patients,it was removed 4～6 h after interventional therapy,and in Group C of ...
Besides, the clinical diagnosis rate of intrahepatic cholestasis of pregnancy (ICP) and Alagille syndrome associated with gene mutation is also increasing. Accordingly, the underlying pathogenesis including abnormal secretion of bile acid, gene mutation, translocation and deletion (JAG1, NOTCH2, ABCG5/...
The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) in hepatocellular carcinoma (HCC) patients is increasing, yet its association with postoperative complications of HCC remains unclear. The aim of this study was to investigate the impact of MAFLD on complications after radical...
doi:10.1002/hep.28906 PubMedGoogle ScholarCrossref 24. Villanueva C, Albillos A, Genescà J, et al. β Blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre...
et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases. Hepatology http://dx.doi.org/10.1002/hep.29367 (2017). Wong, V. W. et al. The Asia-Pacific working party on nonalcoholic fatty liver ...
Uridine is a pyrimidine nucleoside that has been shown to prevent the adverse effects of zalcitabine (ddC) on mitochondrial function in HepG2 cells with respect to lactate synthesis, hepatocyte proliferation, intracellular lipids, and cyclooxygenase-2 levels.⁶² Similarly, in 3T3-F442A preadipoc...
9. Various biological targets of PKC (Protein kinase C) isoform activation 10. Regulating the polyol pathway flux through antioxidant administration 11. Antioxidants and the deactivation of insulin signaling pathway 12. The role of antioxidants on the insulin resistance and atherosclerosis 13. Experimenta...